New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue
to arise and prolong the coronavirus disease 2019 (COVID-19) pandemic. Here, we used a …

RNA amplification tests sensitively detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection, but their complexity and cost are prohibitive for expanding …

The COVID-19 pandemic is among the greatest health and socioeconomic crises in recent
history. Although COVID-19 vaccines are being distributed, there remains a need for rapid …

Background The global need for disease detection and control has increased effort to
engineer point-of-care (POC) tests that are simple, robust, affordable, and non-instrumented. In …

Healthcare delivery has advanced due to the implementation of point-of-care testing, which
is often performed within minutes to hours in minimally equipped laboratories or at home. …

Urine cell-free DNA (cfDNA) is a valuable noninvasive biomarker for cancer mutation detection,
infectious disease diagnosis (eg, tuberculosis), organ transplantation monitoring, and …

Transrenal urine cell-free DNA (cfDNA) is a promising tuberculosis (TB) biomarker, but is
challenging to detect because of the short length (<100 bp) and low concentration of TB-…

Human immunodeficiency virus (HIV) is a chronic infection that can be managed by antiretroviral
treatment (ART). However, periods of suboptimal viral suppression during lifelong ART …

Background Detection of SARS-CoV-2 infections is important for treatment, isolation of infected
and exposed individuals, and contact tracing. RT-qPCR is the "gold-standard" method to …

The increasing prevalence of variant lineages during the COVID-19 pandemic has the
potential to disrupt molecular diagnostics due to mismatches between primers and variant …